text: As required by section 205 , FDA considered regulatory alternatives to the requirements of the rule but determined that the provisions of the final rule constituted the most cost-effective and least burdensome alternative that would meet the objective of the rule .
  
  ###
  
  The FDA considered alternatives and decided to go to a public 's suggestion .